Tesla Motors (NASDAQ:TSLA): Big news from Camp Tesla: the EV maker will be replacing big-data titan Oracle (NASDAQ:ORCL) for its spot on the Nasdaq 100, set to take effect on July 15, when Oracle is scheduled to migrate to the New York Stock Exchange. Tesla has a market capitalization of approximately $12.8 billion.
Dell Inc. (NASDAQ:DELL): Despite the backing from ISS, Michael Dell and Silverlake are still meeting with shareholders to push the merits of their deal, and show how it would be more beneficial than the competing offer from Carl Icahn. Proxy advisory firms Egan-Jones and Glass Lewis have also backed the $24.4 billion bid, though opponents of the buyout offer are also meeting with shareholders to argue against the motion.
Royal Dutch Shell (NYSE:RDSA): Shell has named Ben van Beurden, the head of its Downstream business, as Peter Voser’s replacement for CEO, upon Voser’s stepping down from the post. Van Beurden will take the reigns in January. A 30-year veteran of the company, van Beurden joined Shell in 1983 and has held a number of technical and commercial positions in the company’s Upstream and Downstream operations.
AstraZeneca (NYSE:AZN): The pharmaceutical giant is embarking on three research projects with the University of Cambridge and Cancer Research UK, in an effort to try to identify changes in tumor cells and test combinations of its drugs to better treat some cancer patients. The projects include identifying the presence of tumor DNA in blood plasma, assessing its olaparib treatment for prostate tumors, and developing new therapies for pancreatic cancer.